Connecting you to content on EBSCOhost

Works matching IS 20406207 AND DT 2018 AND VI 9 AND IP 4

Results: 2

1

Pembrolizumab and its role in relapsed/refractory classical Hodgkin's lymphoma: evidence to date and clinical utility.

Published in:

Therapeutic Advances in Hematology, 2018, v. 9, n. 4, p. 89, doi. 10.1177/2040620718761777

By:

Shindiapina, Polina;
Alinari, Lapo

Publication type:

Article

2

Co-expression of MYC and BCL2 predicts poorer outcomes for relapsed/refractory diffuse large B-cell lymphoma with R-ICE and intent to transplant.

Published in:

Therapeutic Advances in Hematology, 2018, v. 9, n. 4, p. 81, doi. 10.1177/2040620718759249

By:

Allen, Joshua;
Ruano Mendez, Ana Lucia;
Rybicki, Lisa;
Sawalha, Yazeed;
Jagadeesh, Deepa;
Dean, Robert;
Pohlman, Brad;
Smith, Mitchell R.;
Hsi, Eric D.;
Hill, Brian T.

Publication type:

Article